Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
451.10    1.10 (0.24%)
Bid:
450.60
Ask:
450.70
Spread: 0.10 (0.022%)
Market Cap: £11.35b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pre stabilisation notice - Rentokil Initial Plc

20 Jun 2022 09:12

RNS Number : 4527P
ING Bank N.V. London Branch
20 June 2022
 

Pré - Stabilisation Notice

ING Bank N.V. (contact: Kris Devos; telephone: 0032 2 557 16 01) hereby gives notice that the Stabilising Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Rentokil Initial Plc

Guarantor (if any):

N/A

Aggregate nominal amount:

N/A

Description:

GBP 10yr

Offer price:

Stabilisation:

Stabilising Manager:

ING Groep

Stabilisation period expected to start on:

20/06/2022

Stabilisation period expected to end no later than:

30 days after the proposed issue date of the securities.

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law.

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom10.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented

 

Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SSDGZGZVRGRGZZG
Date   Source Headline
13th May 20165:04 pmRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSResult of AGM
11th May 20163:59 pmRNSTotal Voting Rights
20th Apr 20167:00 amRNS1st Quarter Results
8th Apr 20164:35 pmRNSAnnual Financial Report - Replacement
8th Apr 20164:08 pmRNSAnnual Financial Report
14th Mar 20167:05 amRNSDirector/PDMR Shareholding
26th Feb 201611:38 amRNSHolding(s) in Company
25th Feb 20167:00 amRNSFinal Results
24th Feb 20164:55 pmRNSHolding(s) in Company
23rd Feb 20161:39 pmRNSHolding(s) in Company
1st Feb 20164:12 pmRNSHolding(s) in Company
28th Jan 20165:26 pmRNSHolding(s) in Company
27th Jan 20164:49 pmRNSHolding(s) in Company
21st Jan 20164:22 pmRNSHolding(s) in Company
15th Jan 201612:33 pmRNSHolding(s) in Company
12th Jan 20166:05 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSRentokil Initial Q4 2015 Acquisitions
25th Nov 20155:17 pmRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
10th Nov 20155:26 pmRNSHolding(s) in Company
6th Nov 201510:46 amRNSChange to Director's details
5th Nov 20157:00 amRNSQ3 Trading Update
20th Oct 20155:08 pmRNSHolding(s) in Company
15th Oct 20159:50 amRNSChange to Director's details
2nd Oct 20157:00 amRNSAcquisition
2nd Sep 20155:19 pmRNSHolding(s) in Company
2nd Sep 20157:00 amRNSHolding(s) in Company
1st Sep 20157:03 amRNSAcquisition
28th Aug 20157:07 amRNSAcquisition
30th Jul 20157:00 amRNSHalf Yearly Report
2nd Jul 20152:00 pmRNSHolding(s) in Company
24th Jun 20153:56 pmRNSDirector/PDMR Shareholding
15th Jun 20155:42 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSDirector/PDMR Shareholding
14th May 20158:12 amRNSResult of AGM
8th May 201510:39 amRNSDirector/PDMR Shareholding
7th May 20153:53 pmRNSHolding(s) in Company
6th May 20155:17 pmRNSHolding(s) in Company
1st May 20157:00 amRNS1st Quarter Results
22nd Apr 20154:01 pmRNSHolding(s) in Company
10th Apr 201510:03 amRNSAnnual Financial Report
8th Apr 20154:34 pmRNSHolding(s) in Company
1st Apr 20154:59 pmRNSDirector/PDMR Shareholding
27th Mar 20154:00 pmRNSHolding(s) in Company
19th Mar 20157:00 amRNSAcquisitions and completion of bond issue
11th Mar 20154:34 pmRNSHolding(s) in Company
10th Mar 20153:54 pmRNSChange to Director's details
5th Mar 201510:21 amRNSHolding(s) in Company
27th Feb 20157:00 amRNSPreliminary Results 31.12.14

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.